[1] Dille BJ, Butzen CC, Birkenmeyer LG. Amplification of Chlamydia trachomatis DNA by ligase chain reaction. J Clin Microbiol, 1993,31:729-731. [2] Schachter J. Chlamydia. In:Albert Balows. Mannual of clinical microbiology. 5th ed. Washington:American Society for Microbiology,1991. 1045. [3] Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in malefemale sexual transmission of human immunodeficiency virus type 1.J Infect Dis, 1991, 163:233-239. [4] Kilmarx PH, Mock PA, Levine WC. Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions. Sex Transm Dis, 2001, 28:347-348. [5] Smith JS, Munoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis,2002, 185:324-331. [6] Tamim H, Finan RR, Sharida HE, et al. Cervieovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis, 2002, 43:277-281. [7] Wallin KL, Wiklund F, Luostarinen T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer, 2002, 101:371-374. [8] Brunham RC, Zhang DJ, Yang X, et al. The potential for vaccine development against chlamydial infection and disease. J Infect Dis,2000, 181 Suppl 3:S538-S543. [9] Kuo LY, Hwang GY, Lai YJ, et al. Overexpression, purification, and characterization of the recombinant leucine aminopeptidase Ⅱ of Bacillus stearothermophilus. Curr Mierobiol, 2003, 47:40-45. |